Back
Benitec Biopharma, Inc. Stock Predictions
Valuation Up 5,000%. Shares Now $0.85 - Still Early?
DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radi
Sell
29
BNTC
Benitec Biopharma, Inc.
Last Price:
$11.50
Seasonality Move:
8.41%
7 Day Trial
ALL ACCESS PASS
$
7
Share Price Moved. Momentum Hasn't Slowed.
DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radiBenitec Biopharma, Inc. Stock Forecast
-
Over the next 52 weeks, Benitec Biopharma, Inc. has on average historically fallen by 1.5% based on the past 11 years of stock performance.
-
Benitec Biopharma, Inc. has fallen lower in 6 of those 11 years over the subsequent 52-week period, corresponding to a historical accuracy of 54.55%
-
Is Benitec Biopharma, Inc. Stock Undervalued?The current Benitec Biopharma, Inc. [BNTC] share price is $11.38. The Score for BNTC is 29, which is 42% below its historic median score of 50, and infers higher risk than normal.
-
BNTC is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
Will Benitec Biopharma, Inc. Stock Go Up Next Year?
-
Over the next 52 weeks, Benitec Biopharma, Inc. has on average historically fallen by 1.5% based on the past 11 years of stock performance.
Benitec Biopharma, Inc. Stock Rating
Sell
29
Benitec Biopharma, Inc. (BNTC)
is a Sell
Is Benitec Biopharma, Inc. overpriced?
-
Benitec Biopharma, Inc. has fallen lower in 6 of those 11 years over the subsequent 52-week period, corresponding to a historical accuracy of 54.55%
Benitec Biopharma, Inc. Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
benitec.com
52-Week Data
52-Week High:
17.15
52-Week Low:
9.70
Prediction Charts
Market Cap:
385.4M
Price in USD:
11.38
Volume:
244.3K
Beta:
1.54
Technical Analysis
SMA50:
13.96
SMA100:
13.54
SMA200:
13.62
52-Wk Change:
-3.89%
Stock Predictions
-
Is Benitec Biopharma, Inc. stock public?Yes, Benitec Biopharma, Inc. is a publicly traded company.
-
What is the Benitec Biopharma, Inc. stock quote today?The Benitec Biopharma, Inc. stock price is 11.38 USD today.
-
How to buy Benitec Biopharma, Inc. stock online?You can buy Benitec Biopharma, Inc. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Dec-1 | 12.82 | 12.23 | 12.82 | 12.18 |
| Dec-2 | 12.25 | 11.65 | 12.96 | 11.54 |
| Dec-3 | 11.74 | 12.58 | 13.00 | 11.65 |
| Dec-4 | 12.49 | 13.18 | 13.22 | 12.49 |
| Dec-5 | 13.26 | 13.58 | 13.68 | 12.70 |
| Dec-8 | 13.62 | 13.19 | 13.62 | 12.82 |
| Dec-9 | 13.20 | 13.32 | 13.47 | 12.78 |
| Dec-10 | 13.32 | 12.81 | 13.33 | 12.80 |
| Dec-11 | 12.88 | 12.96 | 13.05 | 12.70 |
| Dec-12 | 13.03 | 11.98 | 13.03 | 11.92 |
| Dec-15 | 12.02 | 12.18 | 12.44 | 11.88 |
| Dec-16 | 12.11 | 12.41 | 12.99 | 11.76 |
| Dec-17 | 11.91 | 10.79 | 12.47 | 9.93 |
| Dec-18 | 10.86 | 11.38 | 11.56 | 10.46 |
Benitec Biopharma, Inc. Earnings
Benitec Biopharma, Inc. Earnings Report: Per Share Benitec Biopharma, Inc. Earnings Q1 Q2 Q3 and Q4 last year and next year.
Benitec Biopharma, Inc. Forecast Revenue Growth
Benitec Biopharma, Inc. Stock Analysis: Historical quarterly revenues per share for Benitec Biopharma, Inc. and historical quarterly revenue growth:
* Benitec Biopharma, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.